Antiprotozoal Agents < Antipsychotic Agents < Antirheumatic Agents

Facettes :

List of bibliographic references indexed by Antipsychotic Agents

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
000055 (2017)	Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil]	Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
000060 (2017)	Karim Selfani [Canada] ; Valérie L. Soland ; Sylvain Chouinard ; Philippe Huot	Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
000619 (2015)	Hooman Ganjavi [Canada] ; Penny A. Macdonald	ON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
000625 (2015)	Weitao Zhou ; Xiaoyong Li ; Daochao Huang ; Weihui Zhou ; Tingyu Li ; Weihong Song [République populaire de Chine]	No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.
000630 (2015)	Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput	Neuroleptic‐induced Parkinsonism: Clinicopathological study
000689 (2015)	Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]	Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
000971 (2014)	Susan H. Fox [Canada]	Pimavanserin as treatment for Parkinson's disease psychosis.
000A39 (2014)	Payam Piray [Pays-Bas] ; Yashar Zeighami [Canada] ; Fariba Bahrami [Iran] ; Abeer M. Eissa ; Doaa H. Hewedi ; Ahmed A. Moustafa [Pays-Bas]	Impulse control disorders in Parkinson's disease are associated with dysfunction in stimulus valuation but not action valuation.
000B24 (2014)	Philip Seeman [Canada]	Clozapine, a fast-off-D2 antipsychotic.
001267 (2012)	Pierre J. Blanchet [Canada] ; Louise Normandeau ; Pierre H. Rompré	Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
001280 (2012)	Connie Marras [Canada] ; Nathan Herrmann ; Geoffrey M. Anderson ; Hadas D. Fischer ; Xuesong Wang ; Paula A. Rochon	Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
001447 (2012)	Jordan J. Elm [États-Unis]	Design innovations and baseline findings in a long‐term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long‐Term Study–1
001597 (2011)	Gary Remington [Canada] ; Ofer Agid ; George Foussias	Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.
001604 (2011)	M. Hasnain [Canada]	Psychosis in Parkinson's disease: therapeutic options.
001624 (2011)	Jonathan Brotchie [Canada] ; Peter Jenner	New approaches to therapy.
002148 (2008)	Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Richard Williams ; Peter Schieldrop ; Rahul Manchanda ; Ashok Malla ; Raj Harricharan	Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
002500 (2007)	Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada]	Antipsychotic use in older adults with Parkinson's disease
002690 (2007)	Richard Camicioli [Canada] ; Serge Gauthier [Canada]	Clinical trials in Parkinson's disease dementia and dementia with lewy bodies
002757 (2006)	Kelvin L. Chou [États-Unis] ; Joseph H. Friedman	Are atypical antipsychotics associated with a reduced risk of developing parkinsonism?
002962 (2005)	Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Ashok K. Malla ; Rahul Manchanda ; Jatinder Takhar ; Raj Haricharan	Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients.
002981 (2005)	William G. Honer [Canada] ; Lili C. Kopala ; Jonathan Rabinowitz	Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Antipsychotic Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Antipsychotic Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antipsychotic Agents
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022